Synaptogenix Stock Performance
| SNPX Stock | USD 4.57 0.21 4.82% |
Synaptogenix has a performance score of 1 on a scale of 0 to 100. The entity has a beta of -0.0274, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Synaptogenix are expected to decrease at a much lower rate. During the bear market, Synaptogenix is likely to outperform the market. Synaptogenix right now has a risk of 8.02%. Please validate Synaptogenix total risk alpha, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if Synaptogenix will be following its existing price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Synaptogenix are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Synaptogenix may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
Actual Historical Performance (%)
One Day Return 4.94 | Five Day Return (2.85) | Year To Date Return (37.65) | Ten Year Return (94.66) | All Time Return (94.66) |
Last Split Factor 1:25 | Last Split Date 2024-04-05 |
1 | WeWork Trading 216.5 percent Higher - Defense World | 03/26/2024 |
2 | Whats Going On With Synaptogenix Stock | 04/04/2024 |
3 | Acquisition by Schechter Jonathan of 800 shares of Synaptogenix at 5. subject to Rule 16b-3 | 04/08/2024 |
4 | Were Hopeful That Synaptogenix Will Use Its Cash Wisely - Yahoo Movies Canada | 04/16/2024 |
| Begin Period Cash Flow | 37.5 M |
Synaptogenix |
Synaptogenix Relative Risk vs. Return Landscape
If you would invest 508.00 in Synaptogenix on January 25, 2024 and sell it today you would lose (51.00) from holding Synaptogenix or give up 10.04% of portfolio value over 90 days. Synaptogenix is currently generating 0.1507% in daily expected returns and assumes 8.0173% risk (volatility on return distribution) over the 90 days horizon. In different words, 70% of stocks are less volatile than Synaptogenix, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Synaptogenix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Synaptogenix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Synaptogenix, and traders can use it to determine the average amount a Synaptogenix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0188
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | SNPX |
| Negative Returns |
Estimated Market Risk
| 8.02 actual daily | 70 70% of assets are less volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Synaptogenix is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Synaptogenix by adding it to a well-diversified portfolio.
Synaptogenix Fundamentals Growth
Synaptogenix Stock prices reflect investors' perceptions of the future prospects and financial health of Synaptogenix, and Synaptogenix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Synaptogenix Stock performance.
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.15 | ||||
| Current Valuation | (24.13 M) | ||||
| Shares Outstanding | 1.09 M | ||||
| Price To Book | 0.21 X | ||||
| EBITDA | (8.31 M) | ||||
| Net Income | (6.04 M) | ||||
| Cash And Equivalents | 28.75 M | ||||
| Cash Per Share | 4.20 X | ||||
| Current Ratio | 47.22 X | ||||
| Book Value Per Share | 25.27 X | ||||
| Cash Flow From Operations | (5.17 M) | ||||
| Earnings Per Share | (29.50) X | ||||
| Market Capitalization | 4.73 M | ||||
| Total Asset | 31.11 M | ||||
| Retained Earnings | (33.61 M) | ||||
| Working Capital | 26.26 M | ||||
About Synaptogenix Performance
To evaluate Synaptogenix Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Synaptogenix generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Synaptogenix Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Synaptogenix market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Synaptogenix's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00 | 0.00 | |
| Return On Tangible Assets | (0.19) | (0.20) | |
| Return On Capital Employed | (0.31) | (0.33) | |
| Return On Assets | (0.19) | (0.20) | |
| Return On Equity | (0.25) | (0.26) |
Things to note about Synaptogenix performance evaluation
Checking the ongoing alerts about Synaptogenix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Synaptogenix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Synaptogenix had very high historical volatility over the last 90 days | |
| Synaptogenix has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (6.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Synaptogenix currently holds about 28.75 M in cash with (5.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.2. | |
| Synaptogenix has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Were Hopeful That Synaptogenix Will Use Its Cash Wisely - Yahoo Movies Canada |
- Analyzing Synaptogenix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Synaptogenix's stock is overvalued or undervalued compared to its peers.
- Examining Synaptogenix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Synaptogenix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Synaptogenix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Synaptogenix's stock. These opinions can provide insight into Synaptogenix's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synaptogenix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Synaptogenix Stock analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Synaptogenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synaptogenix. If investors know Synaptogenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synaptogenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.50) | Return On Assets (0.15) | Return On Equity (0.20) |
The market value of Synaptogenix is measured differently than its book value, which is the value of Synaptogenix that is recorded on the company's balance sheet. Investors also form their own opinion of Synaptogenix's value that differs from its market value or its book value, called intrinsic value, which is Synaptogenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synaptogenix's market value can be influenced by many factors that don't directly affect Synaptogenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synaptogenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Synaptogenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synaptogenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.